Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Risk stratification after hospitalization for decompensated heart failure.

Felker GM, Leimberger JD, Califf RM, Cuffe MS, Massie BM, Adams KF Jr, Gheorghiade M, O'Connor CM.

J Card Fail. 2004 Dec;10(6):460-6.

PMID:
15599835
2.

Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators.

Circ Heart Fail. 2008 May;1(1):25-33. doi: 10.1161/CIRCHEARTFAILURE.107.746933.

3.

Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study.

Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM; OPTIME-CHF Investigators.

J Am Coll Cardiol. 2003 Mar 19;41(6):997-1003.

4.

Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

O'Connor CM, Abraham WT, Albert NM, Clare R, Gattis Stough W, Gheorghiade M, Greenberg BH, Yancy CW, Young JB, Fonarow GC.

Am Heart J. 2008 Oct;156(4):662-73. doi: 10.1016/j.ahj.2008.04.030.

PMID:
18926148
5.

Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.

Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators.

Circulation. 2005 May 17;111(19):2454-60. Epub 2005 May 2.

6.

Racial differences in the characteristics of patients admitted for acute decompensated heart failure and their relation to outcomes: results from the OPTIME-CHF trial.

Echols MR, Felker GM, Thomas KL, Pieper KS, Garg J, Cuffe MS, Gheorghiade M, Califf RM, O'Connor CM.

J Card Fail. 2006 Dec;12(9):684-8.

PMID:
17174228
7.

Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.

Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M.

J Card Fail. 2007 Jun;13(5):360-4.

PMID:
17602982
8.

Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study.

Rich MW, McSherry F, Williford WO, Yusuf S; Digitalis Investigation Group.

J Am Coll Cardiol. 2001 Sep;38(3):806-13.

9.

Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy CW, Young JB; OPTIMIZE-HF Investigators and Coordinators.

J Am Coll Cardiol. 2008 Jul 29;52(5):347-56. doi: 10.1016/j.jacc.2008.04.028.

10.

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.

Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM.

Am J Cardiol. 2003 Sep 1;92(5):625-8.

PMID:
12943893
11.

Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry.

O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M.

J Card Fail. 2005 Apr;11(3):200-5.

PMID:
15812748
12.

The impact of arrhythmias in acute heart failure.

Benza RL, Tallaj JA, Felker GM, Zabel KM, Kao W, Bourge RC, Pearce D, Leimberger JD, Borzak S, O'connor CM, Gheorghiade M; OPTIME-CHF Investigators.

J Card Fail. 2004 Aug;10(4):279-84.

PMID:
15309692
13.

Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.

Fonarow GC, Peacock WF, Phillips CO, Givertz MM, Lopatin M; ADHERE Scientific Advisory Committee and Investigators.

J Am Coll Cardiol. 2007 May 15;49(19):1943-50. Epub 2007 Apr 30.

14.

Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database.

Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC; ADHERE Scientific Advisory Committee and Investigators.

J Am Coll Cardiol. 2006 Jan 3;47(1):76-84. Epub 2005 Dec 15. Erratum in: J Am Coll Cardiol. 2006 Apr 7;47(7):1502.

15.

Epidemiology and risk stratification in acute heart failure.

Fonarow GC.

Am Heart J. 2008 Feb;155(2):200-7. doi: 10.1016/j.ahj.2006.10.043. Epub 2007 Nov 26. Review.

PMID:
18215587
16.

A simple clinically based predictive rule for heart failure in-hospital mortality.

Rohde LE, Goldraich L, Polanczyk CA, Borges AP, Biolo A, Rabelo E, Beck-Da-Silva L, Clausell N.

J Card Fail. 2006 Oct;12(8):587-93.

PMID:
17045176
17.
18.

Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.

Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM.

Arch Intern Med. 2007 Oct 8;167(18):1998-2005.

PMID:
17923601
19.

Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.

Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.

J Am Coll Cardiol. 2008 Jun 17;51(24):2329-35. doi: 10.1016/j.jacc.2007.11.085.

20.

Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST).

Grayburn PA, Appleton CP, DeMaria AN, Greenberg B, Lowes B, Oh J, Plehn JF, Rahko P, St John Sutton M, Eichhorn EJ; BEST Trial Echocardiographic Substudy Investigators.

J Am Coll Cardiol. 2005 Apr 5;45(7):1064-71.

Items per page

Supplemental Content

Write to the Help Desk